Skip to product information
Green pen on a white background

Mazdutide 10 mg – Multi-Receptor Metabolic Research Peptide

€195,00
Shipping calculated at checkout.
Available Research Formats

Mazdutide (IBI362 / LY3305677, CAS 2259884-03-0): Molecular Mechanism and Metabolic Research Overview

Mazdutide is a synthetic dual peptide agonist studied for its interaction with glucagon-like peptide-1 receptors (GLP-1R) and glucagon receptors (GCGR). Originally developed as LY3305677 and later advanced by Innovent Biologics, it is structurally based on oxyntomodulin (OXM), an endogenous peptide associated with metabolic signaling pathways.

Mazdutide is engineered as a long-acting peptide analog designed to support sustained receptor interaction in experimental and clinical research settings. Its structure combines GLP-1R and GCGR agonism in a balanced signaling profile, making it relevant for studies involving energy regulation, endocrine signaling, and metabolic pathway coordination.

Molecular Design and Receptor Binding

Mazdutide is a linear peptide built on the mammalian oxyntomodulin backbone, which contains the glucagon sequence with an additional C-terminal extension.

Targeted amino acid modifications and lipidation strategies enhance resistance to enzymatic degradation, improve albumin binding, and prolong circulation time in experimental systems.

Both GLP-1R and GCGR belong to the class B G-protein-coupled receptor (GPCR) family. Ligand binding induces conformational changes in extracellular and transmembrane receptor domains, promoting activation of intracellular Gs signaling pathways.

Mazdutide stabilizes active receptor conformations across both receptor systems, enabling coordinated signaling activity.

Downstream Signaling: Cyclic Adenosine Monophosphate (cAMP) Pathways

The primary signaling mechanism for both receptors involves activation of adenylyl cyclase through Gs proteins, leading to elevated intracellular cyclic adenosine monophosphate (cAMP) levels.

Increased cAMP activates protein kinase A (PKA), which modulates multiple downstream cellular processes.

GLP-1R Pathways

GLP-1 receptor signaling is studied in relation to:

• pancreatic endocrine signaling
• gastrointestinal regulatory pathways
• hypothalamic nutrient-sensing systems

GCGR Pathways

Glucagon receptor signaling is associated with:

• hepatic metabolic regulation
• lipid metabolism pathways
• mitochondrial fatty acid oxidation
• energy expenditure signaling systems

Integrated Metabolic Signaling

Mazdutide is studied for its ability to engage both appetite-related and energy-regulation pathways simultaneously.

Research models examine how:

• GLP-1R signaling influences nutrient-related feedback systems
• GCGR activation affects lipid metabolism and mitochondrial activity
• coordinated receptor activation impacts metabolic pathway integration

These pathways are explored in relation to complex endocrine and metabolic signaling networks.

Importance of Balanced Dual Agonism

Native oxyntomodulin naturally interacts with both GLP-1R and GCGR but has limited stability and short duration of activity.

Mazdutide’s structural modifications enhance receptor interaction and signaling persistence while preserving balanced dual agonism across both receptor systems.

This balanced profile is studied for its influence on:

• metabolic flexibility
• mitochondrial energy signaling
• lipid metabolism pathways
• coordinated endocrine regulation

Comparative Overview of Multi-Receptor Metabolic Peptides

Compound Receptors Targeted Agonist Profile CAS Number Research Stage Key Research Focus
Semaglutide GLP-1R GLP-1R agonist 910463-68-2 Approved / extensively studied Appetite and incretin signaling
Tirzepatide GLP-1R + GIPR Dual agonist 2023788-19-2 Approved / extensively studied Multi-incretin metabolic signaling
Retatrutide GLP-1R + GIPR + GCGR Triple agonist 2381089-83-2 Advanced clinical research Multi-receptor energy regulation
Mazdutide GLP-1R + GCGR Dual GLP-1R / GCGR agonist 2259884-03-0 Approved in China / ongoing research Energy expenditure and metabolic signaling

 

Summary

Mazdutide is a dual GLP-1R and GCGR agonist studied for its role in coordinated metabolic signaling and endocrine pathway regulation.

Its mechanisms are associated with:

• cAMP-mediated GPCR signaling
• GLP-1 and glucagon receptor activation
• mitochondrial and lipid metabolism pathways
• integrated energy regulation systems

As a research peptide and metabolic signaling compound, mazdutide is explored to better understand how balanced multi-receptor activation influences complex biological and endocrine networks.

All information presented is based on experimental and clinical research data and is intended for scientific and educational purposes only.

Product Usage

In vitro research or further manufacturing use only. Not for human or animal use.

Peptide Storage

All information provided by PRG is for educational and informational purposes only.

Best Practices for Storing Peptides

To maintain the reliability of laboratory results, correct peptide storage is essential. Proper storage conditions help preserve peptide stability for years while protecting against contamination, oxidation, and breakdown. Although certain peptides are more sensitive than others, following these best practices will greatly extend their shelf life and structural integrity.

  • Short-Term Storage (days to months): Keep peptides cool and protected from light. Temperatures below 4 °C (39 °F) are generally suitable. Lyophilized peptides often remain stable at room temperature for several weeks, but refrigeration is still preferred if use is not immediate.
  • Long-Term Storage (months to years): Store peptides at –80 °C (–112 °F) for maximum stability. Avoid frost-free freezers, as defrost cycles can cause damaging temperature fluctuations.
  • Minimize Freeze–Thaw Cycles: Repeated freezing and thawing accelerates degradation. Instead, divide peptides into aliquots before freezing.

Preventing Oxidation & Moisture Damage

Peptides can be compromised by exposure to moisture and air—especially immediately after removal from a freezer.

  • Let the vial warm to room temperature before opening to prevent condensation.
  • Keep containers sealed as much as possible, and if possible, reseal under a dry, inert gas such as nitrogen or argon.
  • Amino acids like cysteine (C), methionine (M), and tryptophan (W) are particularly sensitive to oxidation.


Storing Peptides in Solution

Peptides in solution have a much shorter lifespan compared to lyophilized form and are prone to bacterial degradation.

  • If storage in solution is unavoidable, use sterile buffers at pH 5–6.
  • Prepare single-use aliquots to avoid repeated freeze–thaw cycles.
  • Most peptide solutions are stable for up to 30 days at 4 °C (39 °F), but sensitive sequences should remain frozen when not in use.


Containers for Peptide Storage

Select containers that are clean, intact, chemically resistant, and appropriately sized for the sample.

  • Glass vials: offer clarity, durability, and chemical resistance.
  • Plastic vials: polystyrene (clear but less resistant) or polypropylene (translucent but chemically resistant).
  • Peptides shipped in plastic vials may be transferred to glass for long-term storage if desired.


Regenesis Peptide Storage Quick Tips

  • Keep peptides in a cold, dry, dark environment
  • Avoid repeated freeze–thaw cycles
  • Minimize exposure to air
  • Protect from light
  • Avoid storing in solution long term
  • Aliquot peptides to match experimental needs
Logo for 'Verified Purity' with a shield design, molecular symbol, and text indicating European laboratory standard.

Analytical Transparency

All PRG research materials are analytically tested for purity and identity under EU laboratory standards. Manufacturer Certificates of Analysis (COA) are available upon request. If independent third-party analytical testing confirms results consistent with our published specifications, PRG may reimburse the verified laboratory testing cost upon review.

You may also like